Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

Key Points Patients with PMF may carry JAK2 (V617F), a CALR exon 9 indel, an MPL exon 10 mutation, or none of these genetic lesions. The genetic subtypes of PMF differ substantially as regards clinical course, disease progression, and overall survival.